Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3502Neoplasms 2744Prostatic Neoplasms 1585Colorectal Neoplasms 1248Lung Neoplasms 1190Motor Activity 768Head and Neck Neoplasms 621Pancreatic Neoplasms 601Colonic Neoplasms 586Uterine Cervical Neoplasms 567Carcinoma, Non-Small-Cell Lung 561Carcinoma, Hepatocellular 561Rectal Neoplasms 516Stomach Neoplasms 493Brain Neoplasms 439Ovarian Neoplasms 401Anxiety Disorders 401Pain 377Esophageal Neoplasms 347Polycystic Ovary Syndrome 341Neoplasm Metastasis 340Fatigue 325Urinary Bladder Neoplasms 315Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 299Depression 286Multiple Myeloma 283Endometrial Neoplasms 264Lymphoma 258Hematologic Neoplasms 251

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER × Cerebral Hemorrhage × Clear all
NCT04291235 2020-03-02

The NEUROlogically-impaired Extubation Timing Trial (NEURO-ETT)

Sunnybrook Health Sciences Centre

Phase NA Unknown
332 enrolled
CNS

Ischemic Stroke, Brain Abscess, Brain Injuries, Brain Neoplasms, Cerebral Hemorrhage, Encephalitis, Heart Arrest, Hematoma, Subdural, Meningitis, Seizures, Subarachnoid Hemorrhage, Diffuse Axonal Injury, Hematoma, Epidural, Spinal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡